|
|
News Breaks
|
March 17, 2010
|
| 06:06 EDT |  | CLRT |
| theflyonthewall.com: | Clarient new data for Ovotax indicates its effectiveness for Ovarian Cancer | | Clarient announced that data from a new study shows that Clarient's Ovotax assay may effectively predict which ovarian cancer patients will respond favorably to taxane therapy and could, therefore, be spared the potential side effects of this rigorous and sometimes toxic chemotherapy agent. The study was presented Tuesday at the national meeting on Women's Cancer of the Society of Gynecologic Oncologists by Janelle Fauci, M.D. of the Department of Obstetrics and Gynecology at the University of Alabama, Birmingham. :theflyonthewall.com |
|
|
News For CLRT From The Last 14 Days Check below for free stories on CLRT the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
